Clinical Trial Update: Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating human ADME properties of [14C]-labeled Ceralasertib (AZD6738) and determining its absolute bioavailability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Ceralasertib (ceralasertib)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasm | Phase 1 | Status: NOT_YET_RECRUITING